oxazolidin-2-one has been researched along with Antibiotic-Associated Colitis in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guery, B | 1 |
Chen, X; Enderlin, M; Fournier, E; Hubschwerlen, C; Keck, W; Kelly, CP; Klenk, A; Locher, HH; Pfaff, P; Ritz, D; Schroeder, S; Seiler, P | 1 |
Clozel, M; Enderlin-Paput, M; Locher, HH; Pfaff, P; Ritz, D; Seiler, P; Weiss, M | 1 |
Freeman, J; Pilling, S; Vernon, J; Wilcox, MH | 1 |
De Lalla, F; Lazzarini, L | 1 |
Worm, S; Zabel, LT | 1 |
Alcalá, L; Alonso, R; Bouza, E; Cuevas, O; Peláez, T; Pérez, C | 1 |
7 other study(ies) available for oxazolidin-2-one and Antibiotic-Associated Colitis
Article | Year |
---|---|
Clostridium difficile infection trials: what is the primary endpoint?
Topics: Clostridioides difficile; Clostridium Infections; Double-Blind Method; Enterocolitis, Pseudomembranous; Humans; Oxazolidinones | 2019 |
In vitro and in vivo antibacterial evaluation of cadazolid, a new antibiotic for treatment of Clostridium difficile infections.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cricetinae; Enterocolitis, Pseudomembranous; Enterotoxins; Female; Fluoroquinolones; Humans; Linezolid; Male; Metronidazole; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Oxazolidinones; Spores, Bacterial; Survival Analysis; Vancomycin | 2014 |
Cadazolid Does Not Promote Intestinal Colonization of Vancomycin-Resistant Enterococci in Mice.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Clostridioides difficile; Colony Count, Microbial; Diarrhea; Enterocolitis, Pseudomembranous; Fidaxomicin; Intestines; Metronidazole; Mice; Microbial Sensitivity Tests; Oxazolidinones; Streptococcal Infections; Treatment Outcome; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2016 |
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Drug Resistance, Multiple, Bacterial; Enterocolitis, Pseudomembranous; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Oxazolidinones; Polymerase Chain Reaction; Pyrrolidines; Quinolones; Ribotyping | 2017 |
Failure of intravenous linezolid to treat Clostridium difficile associated diarrhea.
Topics: Acetamides; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Linezolid; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Risk Assessment | 2003 |
Linezolid contributed to Clostridium difficile colitis with fatal outcome.
Topics: Acetamides; Anti-Infective Agents; Enterocolitis, Pseudomembranous; Fatal Outcome; Humans; Linezolid; Male; Middle Aged; Oxazolidinones | 2005 |
In vitro activity of linezolid against Clostridium difficile.
Topics: Acetamides; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin Resistance | 2002 |